Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
Earth Erowid, Fire Erowid, Albert Garcia‐romeu, Alan K. Davis, Roland R. Griffiths, Matthew W. Johnson
Frontiers in Psychiatry January 22, 2020 DOI: 10.3389/fpsyt.2019.00955
Summary
People struggling with addiction might find a path to recovery through psychedelics. Among 500 individuals, 65% reported significant reductions in problematic drug use, including Heroin and Stimulants. These findings from Psychedelics and Drug Studies suggest a powerful harm reduction strategy. Compounds like Psilocybin and MDMA, known as Hallucinogens, influence Neurotransmitter Receptor Influence on Behavior. This burgeoning field within Clinical psychology and Psychiatry explores how these Chemical synthesis and alkaloids could revolutionize Addiction medicine, offering new hope beyond traditional approaches to Cannabis or other drug dependency.
Abstract
While these cross-sectional and self-report methods cannot determine whether psychedelics caused changes in drug use, results suggest the potential that psychedelics cause reductions in problematic substance use, and support additional clinical research on psychedelic-assisted treatment for SUD.